Cargando…

Vitreomacular interface after anti-VEGF injections in diabetic macular edema

BACKGROUND: The purpose of this study was to evaluate the incidence of vitreomacular adhesion (VMA) release after anti-VEGF therapy for the treatment of diabetic macular edema (DME) and to evaluate further changes in outcome. METHODS: This was a retrospective study that enrolled 66 eyes of 66 patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veloso, Carlos E., Brocchi, Daniel N., Singh, Rishi P., Nehemy, Márcio B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980589/ https://www.ncbi.nlm.nih.gov/pubmed/33741068 http://dx.doi.org/10.1186/s40942-021-00295-8

Ejemplares similares

The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
por: Han, Fangyuan, et al.
Publicado: (2022)

Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy
por: Mikhail, Michael, et al.
Publicado: (2018)

Pars Plana Vitrectomy versus Intravitreal Injection of Ranibizumab in the Treatment of Diabetic Macular Edema Associated with Vitreomacular Interface Abnormalities
por: Elkayal, Hassan, et al.
Publicado: (2021)

Influence of vitreomacular interface score on treatment outcomes of anti-VEGF therapy for neovascular age-related macular degeneration
por: Miyata, Manabu, et al.
Publicado: (2021)

Spontaneous Resolution of Vitreomacular Traction in Two Patients with Diabetic Macular Edema
por: Almeida, David R.P., et al.
Publicado: (2014)

Anti-VEGF for the Management of Diabetic Macular Edema
por: Stefanini, Francisco Rosa, et al.
Publicado: (2014)

Evaluation of Vitrectomy with Planned Foveal Detachment as Surgical Treatment for Refractory Diabetic Macular Edema with or without Vitreomacular Interface Abnormality
por: Abdel Hadi, Ahmed M.
Publicado: (2018)

Cell composition at the vitreomacular interface in traumatic macular holes
por: Guenther, Stefanie R., et al.
Publicado: (2021)

The Vitreomacular Interface in Diabetic Retinopathy
por: Agarwal, Daniel, et al.
Publicado: (2015)

Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema
por: Oshima, Hideyuki, et al.
Publicado: (2022)

Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis
por: Babiuch, Amy S., et al.
Publicado: (2019)

The effect of insulin on response to intravitreal anti-VEGF injection in diabetic macular edema in type 2 diabetes mellitus
por: Gurung, Rajya L., et al.
Publicado: (2022)

Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection
por: Hong, Eun Hee, et al.
Publicado: (2022)

Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study
por: Kulikov, Alexei N, et al.
Publicado: (2017)

Review on Recent Trials Evaluating the Effect of Intravitreal Injections of Anti-VEGF Agents on the Macular Perfusion of Diabetic Patients with Diabetic Macular Edema
por: Elnahry, Ayman G., et al.
Publicado: (2020)

Flavoprotein Fluorescence Correlation with Visual Acuity Response in Patients Receiving Anti-VEGF Injection for Diabetic Macular Edema
por: Andrade Romo, Jorge S., et al.
Publicado: (2018)

Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning
por: Zhang, Ying, et al.
Publicado: (2022)

Regional Variety of Reduction in Retinal Thickness of Diabetic Macular Edema after Anti-VEGF Treatment
por: Yamada, Yutaka, et al.
Publicado: (2022)

Outer retinal tubulation in diabetic macular edema following anti-VEGF treatment
por: Al-Halafi, Ali M
Publicado: (2015)

Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy
por: Nalçacı, Serhad, et al.
Publicado: (2019)

Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review
por: Distefano, Laura N., et al.
Publicado: (2017)

Diabetic macular edema: it is more than just VEGF
por: Singer, Michael A., et al.
Publicado: (2016)

A case report of cystoid macular edema, uveitis and vitreomacular traction in a patient taking Anastrozole
por: Nguyen, Kevin H., et al.
Publicado: (2022)

Vitreomacular Interface Disorders in Behçet’s Uveitis
por: Eser Öztürk, Hilal, et al.
Publicado: (2017)

Expert Panel Consensus for Addressing Anti-VEGF Treatment Challenges of Diabetic Macular Edema in Spain
por: Fernández-Vigo, José Ignacio, et al.
Publicado: (2022)

Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
por: Garoon, Robert B., et al.
Publicado: (2016)

Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
por: Mira, Filipe, et al.
Publicado: (2017)

Foveal Microvascular Integrity Association With Anti-VEGF Treatment Response for Diabetic Macular Edema
por: Huang, Wei-Hsuan, et al.
Publicado: (2021)

Macular Hole Formation after Intravitreal Injection of Bevacizumab for Diabetic Macular Edema
por: Lee, Yun Ji, et al.
Publicado: (2019)

Optical Coherence Tomography Angiography of Macular Perfusion Changes after Anti-VEGF Therapy for Diabetic Macular Edema: A Systematic Review
por: Elnahry, Ayman G., et al.
Publicado: (2021)

Diabetic Macular Edema Before and After Intravitreal Triamcinolone Injection
por: Ramezani, Alireza, et al.
Publicado: (2007)

Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment
por: Kwon, Jin-woo, et al.
Publicado: (2018)

Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant
por: Choi, Moon Young, et al.
Publicado: (2019)

Factors Affecting a Short-Term Response to Anti-VEGF Therapy in Diabetic Macular Edema
por: Usui-Ouchi, Ayumi, et al.
Publicado: (2021)

miRNA Levels as a Biomarker for Anti-VEGF Response in Patients with Diabetic Macular Edema
por: Vader, Maartje J. C., et al.
Publicado: (2021)

Metformin therapy as a strategy to compensate anti-VEGF resistance in patients with diabetic macular edema
por: Uwimana, Alexandre, et al.
Publicado: (2022)

Anti-VEGF Treatment of Diabetic Macular Edema in Denmark: Incidence, Burden of Therapy, and Forecasting Analyses
por: Subhi, Yousif, et al.
Publicado: (2023)

Vitreomacular Interface: From Anterior to Tangential Traction
por: Romano, Mario R., et al.
Publicado: (2015)

Vitelliform Vitreoretinopathy: Clinical Implications of the Vitreomacular Interface
por: Garcia, Giancarlo A., et al.
Publicado: (2020)

Relationship Between Macular Thickness and Visual Acuity in the Treatment of Diabetic Macular Edema With Anti-VEGF Therapy: Systematic Review
por: Wang, Patrick, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v5eopjieebgall36486dfo3dp9